Jupiter Neurosciences Inc (NASDAQ:JUNS) has seen 1.72 million shares traded in the last trading session. The company, currently valued at $75.81M, closed the last trade at $2.29 per share which meant it gained $0.38 on the day or 19.90% during that session. The JUNS stock price is -751.97% off its 52-week high price of $19.51 and 77.73% above the 52-week low of $0.51. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.01 million shares traded. The 3-month trading volume is 436.32K shares.
Jupiter Neurosciences Inc (NASDAQ:JUNS) trade information
Over the past 30 days, the shares of Jupiter Neurosciences Inc (NASDAQ:JUNS) have changed 136.81%. Short interest in the company has seen 0.28 million shares shorted with days to cover at 0.47.
Jupiter Neurosciences Inc (JUNS) estimates and forecasts
The company’s shares have lost -73.53% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 25.26% over the past 5 years.
JUNS Dividends
Jupiter Neurosciences Inc is expected to release its next earnings report on 2025-May-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Jupiter Neurosciences Inc (NASDAQ:JUNS)’s Major holders
Insiders own 54.18% of the company shares, while shares held by institutions stand at 1.17% with a share float percentage of 2.56%. Investors are also buoyed by the number of investors in a company, with Jupiter Neurosciences Inc having a total of 7.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are iShares Trust-iShares Micro-Cap ETF and Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund . As of May 31, 2025 , the former fund manager holds about 0.03% shares in the company for having 11.49 shares of worth $26307.0 while later fund manager owns 9.69 shares of worth $22183.0 as of May 31, 2025 , which makes it owner of about 0.03% of company’s outstanding stock.